SPDEF inhibits prostate carcinogenesis by disrupting a positive feedback loop in regulation of the Foxm1 oncogene.
SAM-pointed domain-containing ETS transcription factor (SPDEF) is expressed in normal prostate epithelium. While its expression changes during prostate carcinogenesis (PCa), the role of SPDEF in prostate cancer remains controversial due to the lack of genetic mouse models. In present study, we gener...
Main Authors: | Xin-Hua Cheng, Markaisa Black, Vladimir Ustiyan, Tien Le, Logan Fulford, Anusha Sridharan, Mario Medvedovic, Vladimir V Kalinichenko, Jeffrey A Whitsett, Tanya V Kalin |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-09-01
|
Series: | PLoS Genetics |
Online Access: | http://europepmc.org/articles/PMC4177813?pdf=render |
Similar Items
-
Loss of FOXM1 in macrophages promotes pulmonary fibrosis by activating p38 MAPK signaling pathway.
by: Chinmayee Goda, et al.
Published: (2020-04-01) -
FOXM1 activates AGR2 and causes progression of lung adenomas into invasive mucinous adenocarcinomas.
by: David Milewski, et al.
Published: (2017-12-01) -
Expression of Foxm1 transcription factor in cardiomyocytes is required for myocardial development.
by: Craig Bolte, et al.
Published: (2011-01-01) -
Double Agent: SPDEF Gene with Both Oncogenic and Tumor-Suppressor Functions in Breast Cancer
by: Ye T, et al.
Published: (2020-05-01) -
Role of SPDEF in Prostate Cancer
by: Gao, Chen
Published: (2012)